Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00710255 · ClinicalTrials.gov registry record
Role of Leukotrienes and Adenosine in Hyperpnea-induced Bronchospasm
A clinical trial of Asthma, Exercise Induced, sponsored by University of Vermont.
- Completed
- Registry status
- 8
- Enrollment target
- 1
- Study location
NCT00710255: Completed study of Asthma, Exercise Induced, sponsored by University of Vermont.
NCT00710255 is a study of Asthma, Exercise Induced that has completed, run by University of Vermont. The registered enrollment target is 8 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00710255, a study of Asthma, Exercise Induced, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
This research is being conducted to help us better understand what causes exercise induced asthma. The investigators hypothesize that two types of chemicals, cysteinyl leukotrienes and adenosine, play an important role. The investigators will be measuring these chemicals in the exhaled breath of volunteers with exercise induced asthma as they undergo a test to mimic exercise induced asthma. The investigators will determine how the levels of these chemicals change in association with how lung function changes before, during and after an episode of exercise induced asthma.
Conditions Studied
Interventions
- PROCEDURE Hyperpnea challenge
Study Locations (1)
Vermont
- Vermont Lung Center - Colchester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2007-10 |
| Est. Completion | 2009-07 |
What the finished NCT00710255 record still lists
NCT00710255 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 1 condition, with Asthma, Exercise Induced appearing as the primary indexed condition, and to 1 intervention - of which Hyperpnea challenge is the first listed.
NCT00710255 reports a single indexed study location in Vermont.
Frequently Asked Questions
What is clinical trial NCT00710255 about?
NCT00710255 is a clinical study titled "Role of Leukotrienes and Adenosine in Hyperpnea-induced Bronchospasm". This research is being conducted to help us better understand what causes exercise induced asthma. The investigators hypothesize that two types of chemicals, cysteinyl leukotrienes and adenosine, play an important role. The investigators will be measuring these chemicals in the exhaled breath of vol...
What is the current status of trial NCT00710255?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2007-10. Estimated completion is 2009-07.
What conditions does trial NCT00710255 study?
This clinical trial studies the following conditions: Asthma, Exercise Induced.
What interventions are being tested in trial NCT00710255?
The interventions under investigation include: Hyperpnea challenge (PROCEDURE).
Who is sponsoring clinical trial NCT00710255?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00710255 being conducted?
This trial has 1 study location across Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia